Preserved heart failure trial misses endpoint, but drug may benefit some patients
The number of patients with heart failure with preserved ejection fraction is on the rise, and the search is on for a therapy that can improve health outcomes in this group of patients for whom no approved therapies are available. ...
Sep 1, 2019
0
1